Imeglimin to the Rescue: Enhanced CHOP/GADD34/ eIF2a Signaling Axis Promotes β-Cell Survival

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish (US)
Pages (from-to)376-378
Number of pages3
Issue number3
StatePublished - Mar 2022

Bibliographical note

Funding Information:
Funding. Work in the E.U.A. laboratory is supported by the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Disease (R01 DK115720), National Institute of Child Health and Human Development (R21 HD100840), and the McKnight Foundation. Duality of Interest. No potential conflicts of interest relevant to this article were reported.

PubMed: MeSH publication types

  • Journal Article
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

Cite this